Trial NCT02987998

View at ClinicalTrials.gov 
Org. Study IDs: CASE4516

Last trial update was posted on 2022-12-19

MeSH Interventions

Etoposide Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Stage IIIA Non-Small Cell Lung Cancer

Stopping Reasons

higher than expected rate of toxicity & unrealistic timeline to complete trial under company's proposed plan to reopen

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID